11-70471335-C-CA
Variant names:
Variant summary
Our verdict is Benign. The variant received -9 ACMG points: 0P and 9B. BP6BS1BS2
The NM_012309.5(SHANK2):c.*1533dupT variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00216 in 398,676 control chromosomes in the GnomAD database, including 5 homozygotes. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Genomes: 𝑓 0.0019 ( 4 hom., cov: 33)
Exomes 𝑓: 0.0023 ( 1 hom. )
Consequence
SHANK2
NM_012309.5 3_prime_UTR
NM_012309.5 3_prime_UTR
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 0.143
Publications
0 publications found
Genes affected
SHANK2 (HGNC:14295): (SH3 and multiple ankyrin repeat domains 2) This gene encodes a protein that is a member of the Shank family of synaptic proteins that may function as molecular scaffolds in the postsynaptic density of excitatory synapses. Shank proteins contain multiple domains for protein-protein interaction, including ankyrin repeats, and an SH3 domain. This particular family member contains a PDZ domain, a consensus sequence for cortactin SH3 domain-binding peptides and a sterile alpha motif. The alternative splicing demonstrated in Shank genes has been suggested as a mechanism for regulating the molecular structure of Shank and the spectrum of Shank-interacting proteins in the postsynaptic densities of the adult and developing brain. Alterations in the encoded protein may be associated with susceptibility to autism spectrum disorder. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Feb 2014]
SHANK2 Gene-Disease associations (from GenCC):
- complex neurodevelopmental disorderInheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
- autism, susceptibility to, 17Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -9 ACMG points.
BP6
Variant 11-70471335-C-CA is Benign according to our data. Variant chr11-70471335-C-CA is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 305892.We mark this variant Likely_benign, oryginal submissions are: {Uncertain_significance=1, Benign=1}.
BS1
Variant frequency is greater than expected in population amr. GnomAd4 allele frequency = 0.00195 (296/151950) while in subpopulation AMR AF = 0.00386 (59/15270). AF 95% confidence interval is 0.00308. There are 4 homozygotes in GnomAd4. There are 144 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High AC in GnomAd4 at 296 AD gene.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00194 AC: 294AN: 151846Hom.: 4 Cov.: 33 show subpopulations
GnomAD3 genomes
AF:
AC:
294
AN:
151846
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.00229 AC: 566AN: 246726Hom.: 1 Cov.: 0 AF XY: 0.00226 AC XY: 282AN XY: 125050 show subpopulations
GnomAD4 exome
AF:
AC:
566
AN:
246726
Hom.:
Cov.:
0
AF XY:
AC XY:
282
AN XY:
125050
show subpopulations
African (AFR)
AF:
AC:
5
AN:
7180
American (AMR)
AF:
AC:
13
AN:
7434
Ashkenazi Jewish (ASJ)
AF:
AC:
46
AN:
9240
East Asian (EAS)
AF:
AC:
0
AN:
22894
South Asian (SAS)
AF:
AC:
8
AN:
3032
European-Finnish (FIN)
AF:
AC:
6
AN:
21242
Middle Eastern (MID)
AF:
AC:
17
AN:
1294
European-Non Finnish (NFE)
AF:
AC:
431
AN:
158036
Other (OTH)
AF:
AC:
40
AN:
16374
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.485
Heterozygous variant carriers
0
35
70
106
141
176
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome AF: 0.00195 AC: 296AN: 151950Hom.: 4 Cov.: 33 AF XY: 0.00194 AC XY: 144AN XY: 74224 show subpopulations
GnomAD4 genome
AF:
AC:
296
AN:
151950
Hom.:
Cov.:
33
AF XY:
AC XY:
144
AN XY:
74224
show subpopulations
African (AFR)
AF:
AC:
25
AN:
41436
American (AMR)
AF:
AC:
59
AN:
15270
Ashkenazi Jewish (ASJ)
AF:
AC:
23
AN:
3466
East Asian (EAS)
AF:
AC:
0
AN:
5178
South Asian (SAS)
AF:
AC:
15
AN:
4802
European-Finnish (FIN)
AF:
AC:
3
AN:
10512
Middle Eastern (MID)
AF:
AC:
3
AN:
292
European-Non Finnish (NFE)
AF:
AC:
163
AN:
67980
Other (OTH)
AF:
AC:
5
AN:
2106
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.497
Heterozygous variant carriers
0
15
30
46
61
76
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
6
AN:
3478
ClinVar
Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:1
Revision: criteria provided, conflicting classifications
LINK: link
Submissions by phenotype
Autism spectrum disorder Uncertain:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
not provided Benign:1
Jan 01, 2023
CeGaT Center for Human Genetics Tuebingen
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
SHANK2: BS1, BS2 -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.